BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 22487944)

  • 21. [Current value of intrapleural fibrinolysis in the treatment of exudative fibrinous pleural effusions in pleural empyema and hemothorax].
    Kemper P; Köhler D
    Pneumologie; 1999 Aug; 53(8):373-84. PubMed ID: 10483276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness of intrapleural use of tissue plasminogen activator and DNase in pleural infection: evidence from the MIST2 randomised controlled trial.
    Luengo-Fernandez R; Penz E; Dobson M; Psallidas I; Nunn AJ; Maskell NA; Rahman NM
    Eur Respir J; 2019 Aug; 54(2):. PubMed ID: 31097519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intrapleural tissue plasminogen activator and deoxyribonuclease administered concurrently and once daily for complex parapneumonic pleural effusion and empyema.
    Smith D; Shaw H; Ryder T
    Intern Med J; 2023 Dec; 53(12):2313-2318. PubMed ID: 37029951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modified regimen intrapleural alteplase with pulmozyme in pleural infection management: a tertiary teaching hospital experience.
    Cheong XK; Ban AY; Ng BH; Nik Abeed NN; Nik Ismail NA; Nik Fuad NF; Syed Zakaria SZ; Ghan SL; Abdul Hamid MF
    BMC Pulm Med; 2022 May; 22(1):199. PubMed ID: 35581627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intrapleural tissue plasminogen activator and deoxyribonuclease therapy for pleural infection.
    Piccolo F; Popowicz N; Wong D; Lee YC
    J Thorac Dis; 2015 Jun; 7(6):999-1008. PubMed ID: 26150913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intrapleural fibrinolysis and DNase versus video-assisted thoracic surgery (VATS) for the treatment of pleural empyema (FIVERVATS): protocol for a randomised, controlled trial - surgery as first-line treatment.
    Christensen TD; Bendixen M; Skaarup SH; Jensen JU; Petersen RH; Christensen M; Licht P; Neckelmann K; Bibby BM; Møller LB; Bodtger U; Borg MH; Saghir Z; Langfeldt S; Harders SMW; Bedawi EO; Naidu B; Rahman N; Laursen CB
    BMJ Open; 2022 Mar; 12(3):e054236. PubMed ID: 35264347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes of Pleural Space Infections in Patients With Indwelling Pleural Catheters for Active Malignancies.
    Chang CH; Ost DE; Jimenez CA; Saltijeral SN; Eapen GA; Casal RF; Sabath BF; Lin J; Cerrillos E; Nevarez Tinoco T; Grosu HB
    J Bronchology Interv Pulmonol; 2024 Apr; 31(2):155-159. PubMed ID: 37982602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intrapleural Dornase and Tissue Plasminogen Activator in pediatric empyema (DTPA): a study protocol for a randomized controlled trial.
    Livingston MH; Mahant S; Ratjen F; Connolly BL; Thorpe K; Mamdani M; Maclusky I; Laberge S; Giglia L; Walton JM; Yang CL; Roberts A; Shawyer AC; Brindle M; Parsons SJ; Stoian CA; Cohen E
    Trials; 2017 Jun; 18(1):293. PubMed ID: 28646887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Retrospective Cohort Study Evaluating the Safety and Efficacy of Sequential versus Concurrent Intrapleural Instillation of Tissue Plasminogen Activator and DNase for Pleural Infection.
    Goh KJ; Chew WM; Ong JCL; Leong CK; Mohamed Noor IB; Anantham D; Hui LYS; Choong MCM; Liew CJY; Gutierrez MT; Wong JJY; Phua IGCS; Lim WT; Tan QL
    Pulm Med; 2023; 2023():6340851. PubMed ID: 38146504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of intrapleural instillation of fibrinolytics for treating pleural empyema and parapneumonic effusion: a meta-analysis of randomized control trials.
    Nie W; Liu Y; Ye J; Shi L; Shao F; Ying K; Zhang R
    Clin Respir J; 2014 Jul; 8(3):281-91. PubMed ID: 24428897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and Efficacy of Intrapleural Tissue Plasminogen Activator and DNase during Extended Use in Complicated Pleural Space Infections.
    McClune JR; Wilshire CL; Gorden JA; Louie BE; Farviar AS; Stefanski MJ; Vallieres E; Aye RW; Gilbert CR
    Can Respir J; 2016; 2016():9796768. PubMed ID: 27445574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Intrapleural Fibrinolytic Therapy vs Surgery for Complicated Pleural Infections: A Randomized Clinical Trial.
    Wilshire CL; Jackson AS; Vallières E; Bograd AJ; Louie BE; Aye RW; Farivar AS; White PT; Gilbert CR; Gorden JA
    JAMA Netw Open; 2023 Apr; 6(4):e237799. PubMed ID: 37043201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of intrapleural tissue plasminogen activator and deoxyribonuclease in pleural space infections: an update on alternative regimens.
    Gilbert CR; Gorden JA
    Curr Opin Pulm Med; 2017 Jul; 23(4):371-375. PubMed ID: 28399008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biological effect of tissue plasminogen activator (t-PA) and DNase intrapleural delivery in pleural infection patients.
    Kanellakis NI; Wrightson JM; Hallifax R; Bedawi EO; Mercer R; Hassan M; Asciak R; Hedley E; Dobson M; Dong T; Psallidas I; Rahman NM
    BMJ Open Respir Res; 2019; 6(1):e000440. PubMed ID: 31673364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New therapeutic approaches to pleural infection.
    Corcoran JP; Hallifax R; Rahman NM
    Curr Opin Infect Dis; 2013 Apr; 26(2):196-202. PubMed ID: 23286936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intrapleural therapy.
    Huggins JT; Doelken P; Sahn SA
    Respirology; 2011 Aug; 16(6):891-9. PubMed ID: 21672085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intrapleural fibrinolytic therapy for pleural infection.
    Bouros D; Tzouvelekis A; Antoniou KM; Heffner JE
    Pulm Pharmacol Ther; 2007; 20(6):616-26. PubMed ID: 17049447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intrapleural Fibrinolysis for the Treatment of Indwelling Pleural Catheter-Related Symptomatic Loculations: A Multicenter Observational Study.
    Thomas R; Piccolo F; Miller D; MacEachern PR; Chee AC; Huseini T; Yarmus L; Bhatnagar R; Lee HJ; Feller-Kopman D; Maskell NA; Tremblay A; Lee YCG
    Chest; 2015 Sep; 148(3):746-751. PubMed ID: 25742001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current use of intrapleural tissue plasminogen activator in the treatment of complex pleural processes: a review of the literature and report of 9 cases.
    Dulaney CR; Merrill WH; Tesseneer S; Jenkins-Lonidier L; Tribble CG
    J Miss State Med Assoc; 2012 Jul; 53(7):216-9. PubMed ID: 23066590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intrapleural Fibrinolytic Therapy versus Early Medical Thoracoscopy for Treatment of Pleural Infection. Randomized Controlled Clinical Trial.
    Kheir F; Thakore S; Mehta H; Jantz M; Parikh M; Chee A; Kaphle U; Sisnega C; Fernandez-Bussy S; Majid A
    Ann Am Thorac Soc; 2020 Aug; 17(8):958-964. PubMed ID: 32421353
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.